Goldman Sachs’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
VCM
BL
FLPIM
VFT
CM
Goldman Sachs's GNLX Position: Q1 2026 in Review
Goldman Sachs reduced its Genelux (GNLX) stake by 82% in Q1 2026, selling an estimated $412K and leaving 32,610 shares worth $78.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6238.
Goldman Sachs first reported a position in GNLX in Q1 2023 and has held it in 9 quarters since. The position peaked at $801K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.
- Goldman Sachs held 32,610 shares of Genelux worth $78.9K as of Q1 2026.
- Goldman Sachs sold 151,197 Genelux shares in Q1 2026, an estimated $412K.
- Genelux made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6238 holding.
- Goldman Sachs first reported a position in Genelux in Q1 2023 and has held it in 9 quarters since.
- Goldman Sachs's Genelux position peaked at $801K in Q4 2025.
- 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.